ALBERICI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 3.829
AS - Asia 3.172
EU - Europa 2.213
SA - Sud America 351
Continente sconosciuto - Info sul continente non disponibili 325
AF - Africa 66
OC - Oceania 42
Totale 9.998
Nazione #
US - Stati Uniti d'America 3.625
CN - Cina 1.138
SG - Singapore 723
IT - Italia 536
GB - Regno Unito 419
JP - Giappone 254
HK - Hong Kong 205
VN - Vietnam 202
BR - Brasile 185
RU - Federazione Russa 184
ES - Italia 174
DE - Germania 173
FR - Francia 165
IN - India 144
BD - Bangladesh 142
CA - Canada 87
MX - Messico 86
IE - Irlanda 81
TR - Turchia 77
NL - Olanda 59
SE - Svezia 59
AR - Argentina 57
ID - Indonesia 52
KR - Corea 51
CO - Colombia 46
FI - Finlandia 42
PL - Polonia 42
CH - Svizzera 39
AU - Australia 37
AT - Austria 34
GR - Grecia 28
NO - Norvegia 26
TW - Taiwan 26
PT - Portogallo 23
CL - Cile 21
IR - Iran 20
BE - Belgio 19
DK - Danimarca 19
PE - Perù 18
UA - Ucraina 18
IL - Israele 17
MA - Marocco 17
MY - Malesia 16
SA - Arabia Saudita 16
RS - Serbia 14
ZA - Sudafrica 14
EG - Egitto 13
RO - Romania 13
TH - Thailandia 13
IQ - Iraq 12
HU - Ungheria 11
PK - Pakistan 11
CI - Costa d'Avorio 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
NP - Nepal 8
CR - Costa Rica 7
HR - Croazia 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 5
GT - Guatemala 5
JO - Giordania 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PH - Filippine 5
AM - Armenia 4
KE - Kenya 4
KW - Kuwait 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
BS - Bahamas 3
DZ - Algeria 3
EU - Europa 3
HT - Haiti 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
PR - Porto Rico 3
SI - Slovenia 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
QA - Qatar 2
AZ - Azerbaigian 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
Totale 9.672
Città #
Singapore 425
Ashburn 313
Southend 242
Beijing 204
Fairfield 202
Redwood City 172
Santa Clara 161
Hong Kong 153
San Jose 138
Dearborn 132
Chandler 122
Milan 105
Woodbridge 105
Council Bluffs 102
Seattle 92
Guangzhou 88
New York 87
Los Angeles 86
Houston 83
Dublin 80
Cambridge 78
Princeton 76
Dallas 74
Tokyo 74
Shanghai 72
Nanjing 71
Wilmington 70
Ann Arbor 63
Ho Chi Minh City 61
Phoenix 57
Des Moines 47
Hanoi 46
Lauterbourg 39
Moscow 39
Helsinki 37
Jakarta 36
Buffalo 32
Rome 32
Madrid 31
Barcelona 30
Bengaluru 30
Frankfurt am Main 28
Istanbul 28
Hangzhou 27
Hefei 27
Boardman 26
Central District 26
Mexico City 26
Seoul 26
Shenyang 26
São Paulo 26
Columbus 25
London 25
Nanchang 25
The Dalles 23
Florence 21
Montreal 21
Vienna 21
Zurich 21
Buenos Aires 20
Chengdu 20
Warsaw 20
Changsha 19
Orem 19
Paris 19
Zhengzhou 19
Jinan 18
Tianjin 18
Brescia 17
Chicago 17
Bathinda 16
Delhi 16
Falls Church 16
Naples 16
Wuhan 16
Bogotá 15
Bologna 15
Chongqing 15
Mumbai 15
Brooklyn 14
Athens 13
Chennai 13
Da Nang 13
Riyadh 13
Santiago 13
Ankara 12
Medellín 12
Nuremberg 12
Ottawa 12
Silver Spring 12
Washington 12
Atlanta 11
Cinisello Balsamo 11
Denver 11
Haiphong 11
Hebei 11
New Delhi 11
San Diego 11
San Francisco 11
Taipei 11
Totale 5.231
Nome #
Lupus nephritis and B-cell targeting therapy 1.485
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis 1.049
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients 815
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 459
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis 385
Chronic periaortitis with thoracic aorta and epiaortic artery involvement : a systemic large vessel vasculitis? 379
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study 354
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis 255
Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature 250
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 235
PTPN22 R620W polymorphism in the ANCA-associated vasculitides 224
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 223
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index 222
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis 222
Genetics of ANCA-Associated Vasculitis 201
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis : a randomised trial 197
Update on ANCA-associated vasculitis : from biomarkers to therapy 193
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 183
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 177
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN 171
Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation 152
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC) : a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC) 151
FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome 151
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC) 123
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 119
The role of analytical methods for the determination of trace elements in environmental biomonitors 119
Prevention of arterial thrombosis recurrence in anti-phospholipid syndrome: are anti-platelets the answer? 116
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis 114
Incremental peritoneal dialysis: less is more—for the patient and the planet 109
Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis 108
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 107
Impact of rituximab trials on the treatment of ANCA-associated vasculitis 102
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-alpha in patients with renal cell carcinoma 99
Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile 94
Rituximab-associated hypogammaglobulinemia : incidence, predictors and outcomes in patients with multi-system autoimmune disease 93
Orofacial granulomatosis treated with low-level laser therapy: a case report 84
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial 84
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease : a case series 84
Genetics of ANCA-associated vasculitides: HLA and beyond 79
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 78
Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms 78
IgG4 immune response in Churg-Strauss syndrome 75
Totale 9.998
Categoria #
all - tutte 24.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022655 0 53 38 62 55 52 60 51 73 59 39 113
2022/2023809 107 37 27 70 80 125 33 72 127 26 65 40
2023/2024732 52 59 35 53 146 44 42 53 42 51 64 91
2024/20251.368 57 136 45 93 182 88 66 166 85 111 132 207
2025/20262.811 227 89 217 288 389 195 371 135 293 186 218 203
2026/2027407 201 206 0 0 0 0 0 0 0 0 0 0
Totale 9.998